Table 2.
Stimulation‐induced side effects (SEs)
Initial Visit | 12‐Week Follow‐up | |||
---|---|---|---|---|
Standard Care (n = 11) | Experimental Treatment (n = 11) | Standard Care (n = 9) | Experimental Treatment (n = 9) | |
Dysarthria | 4 | 7 | 4 | 5 |
Ataxia | 3 | 5 | 3 | 4 |
Dysphagia | 2 | 0 | 0 | 0 |
Tingling in tongue | 1 | 0 | 1 | 0 |
Transient dizziness | 1 | 0 | 1 | 0 |
No. of patients with stim SEs | 6 | 7 | 5 | 5 |
Percentage reporting stim SEs | 54.5 | 63.6 | 55.6 | 55.6 |